🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an observational study to collect data from Japanese babies with re...
Status
Active Not Recruiting
Location
Many locations
Start Date
2023-03-27
Trial ID
NCT05705258
Treatments Being Tested
The Endurance Trial is a phase IV open label clinical study to assess the n...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02297204
Treatments Being Tested
Phase 2 open label, randomized, active controlled, dose-ranging trial in ad...
Status
Recruiting
Location
Sierra Eye Associates
Start Date
2025-03-18
Trial ID
NCT06942520
Treatments Being Tested
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of X-82 in...
Status
Terminated
Location
Multiple Locations
Start Date
2015-03-16
Trial ID
NCT02348359
Regeneron Pharmaceuticals developed a single-dose pre-filled syringe (PFS) ...
Status
Completed
Location
Retina Consultants of Texas
Start Date
2024-04-15
Trial ID
NCT05989126
Treatments Being Tested
To assess the efficacy of intravitreal (IVT) administration of aflibercept ...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-19
Trial ID
NCT02305238
Treatments Being Tested
A Phase 2, Multi-Center, Randomized, Double-Masked\*, Active Controlled Stu...
Status
Completed
Location
Adverum Clinical Site
Start Date
2020-05-28
Trial ID
NCT04418427
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of ESBA1008...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01796964
Treatments Being Tested
The currently widely established and preferred protocol for the treatment o...
Status
Active Not Recruiting
Location
Berner Augenklinik
Start Date
2022-05-09
Trial ID
NCT04932980
Treatments Being Tested